Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

著者: Funda Meric‐Bernstam, Herbert I. Hurwitz, Kanwal Raghav, Robert R. McWilliams, Marwan Fakih, Ari M. Vanderwalde, Charles Swanton, Razelle Kurzrock, Howard A. Burris, Christopher J. Sweeney, Ron Bose, David R. Spigel, Mary Beattie, Steven Blotner, Alyssa Stone, Katja Schulze, Vaikunth Cuchelkar, John D. Hainsworth - The Lancet 2019 被引用: 564